Back
Energy Fuels 10K Form
Buy
63
UUUU
Energy Fuels
Last Price:
7.08
Seasonality Move:
22.26%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2023-11-06 | 10Q | UUUU/Energy Fuels Quarterly |
2023-08-04 | 10Q | UUUU/Energy Fuels Quarterly |
2023-05-05 | 10Q | UUUU/Energy Fuels Quarterly |
2022-11-04 | 10Q | UUUU/Energy Fuels Quarterly |
2022-08-05 | 10Q | UUUU/Energy Fuels Quarterly |
2022-05-16 | 10Q | UUUU/Energy Fuels Quarterly |
Receive UUUU News And Ratings
See the #1 stock for the next 7 days that we like better than UUUU
UUUU Financial Statistics
Sales & Book Value
Annual Sales: | $37.93M |
---|---|
Cash Flow: | $-14.65M |
Price / Cash Flow: | 0 |
Annual Sales: | $2.26 |
Price / Book: | 3.85 |
Profitability
EPS (TTM): | -0.22000 |
---|---|
Net Income (TTM): | $-34.95M |
Gross Margin: | $19.75M |
Return on Equity: | -9.15% |
Return on Assets: | -8.68% |
Energy Fuels Earnings Forecast
Key Energy Fuels Financial Ratios
- The Gross Profit Margin over the past 15 years for UUUU is 52.06%.
- The Selling, General & Administrative Expenses for UUUU have been equal to 73.60% of Gross Profit Margin.
- The Research & Development expenses have been 31.24% of Revenue.
- The Interest Expense is -0.28% of Operating Income.
- The Net Earning history of UUUU is 263.29% of Total Revenues.
- Per Share Earnings over the last 24 years have been positive in 17 years.
Energy Fuels Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NYAM |
---|---|
Industry: | Oil, Gas & Consumable Fuels |
Sector: | Energy |
Current Symbol: | UUUU |
CUSIP: | 292671 |
Website: | energyfuels.com |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 18.01 |
Quick Ratio: | 14.26 |
Price-to-Earnings
Trailing P/E Ratio: | 11.76 |
---|---|
Forward P/E Ratio: | 0 |
UUUU Technical Analysis vs Fundamental Analysis
Buy
63
Energy Fuels (UUUU)
is a Buy
Is Energy Fuels a Buy or a Sell?
-
Energy Fuels stock is rated a Buy
The current Energy Fuels [UUUU] share price is $6.94. The Score for UUUU is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.